Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1986;111(2):166-8.
doi: 10.1007/BF00400758.

Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III). A representative of a new class of inorganic antitumor agents

Comparative Study

Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III). A representative of a new class of inorganic antitumor agents

B K Keppler et al. J Cancer Res Clin Oncol. 1986.

Abstract

The antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III) against the P388 leukemia and against the B16 melanoma was investigated. The test compound showed high activity against these tumor models. The tumor inhibiting effect was in the range or better than the effects of the compounds cyclophosphamide, cisplatin, or 5-fluorouracil, which were tested as positive controls. The effective substance is a new, water soluble, anionic, nitrogen-heterocyclic coordinated, ruthenium species, exhibiting antitumor activity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Berger MR, Bischoff H, Hermanek P, Schmähl D (1984) Biological characterization and chemotherapy of autochthonous colorectal tumors in rats. In: Klein HO (ed) Advances in the chemotherapy of gastrointestinal cancer. Perimed-Fachbuch-Verlagsgesellschaft, Erlangen, pp 75–81
    1. Clarke MJ (1980) Oncological implications of the chemistry of ruthnium. In: Sigel H (ed) Metal ions in biological systems volume 11, metal complexes as anticancer agents. Marcel Dekker, Inc., Basel, New York, pp 231–276
    1. Cleare MJ, Hydes PC (1980) Antitumor properties of metal complexes. In: Sigel H (ed) Metal ions in biological systems volume II, metal complexes as anticancer agents. Marcel Dekker, Inc., Basel, New York, pp 1–56
    1. Keller HJ, Keppler BK, Schmähl D (1982) Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)-titanium(IV) compounds against Walker 256 carcinosarcoma. Drug Res 8:806–807 - PubMed
    1. Keppler BK, Diez A, Seifried V (1985) Antitumor activity of phenyl substituted dihalogenobis(1-phenyl-1,3-butanedionato)titanium-(IV) compounds. Drug Res 35(II) 12:1832–1836 - PubMed

Publication types

LinkOut - more resources